FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2054255517> ?p ?o ?g. }

• W2054255517 endingPage "e58424" @default.
• W2054255517 startingPage "e58424" @default.
• W2054255517 abstract "CD56 is expressed in 15–20% of acute myeloid leukaemias (AML) and is associated with extramedullary diffusion, multidrug resistance and poor prognosis. We describe the establishment and characterisation of a novel disseminated model of AML (AML-NS8), generated by injection into mice of leukaemic blasts freshly isolated from a patient with an aggressive CD56+ monoblastic AML (M5a). The model reproduced typical manifestations of this leukaemia, including presence of extramedullary masses and central nervous system involvement, and the original phenotype, karyotype and genotype of leukaemic cells were retained in vivo. Recently Polo-Like Kinase 1 (PLK1) has emerged as a new candidate drug target in AML. We therefore tested our PLK1 inhibitor NMS-P937 in this model either in the engraftment or in the established disease settings. Both schedules showed good efficacy compared to standard therapies, with a significant increase in median survival time (MST) expecially in the established disease setting (MST = 28, 36, 62 days for vehicle, cytarabine and NMS-P937, respectively). Importantly, we could also demonstrate that NMS-P937 induced specific biomarker modulation in extramedullary tissues. This new in vivo model of CD56+ AML that recapitulates the human tumour lends support for the therapeutic use of PLK1 inhibitors in AML." @default.
• W2054255517 created "2016-06-24" @default.
• W2054255517 creator A5002145082 @default.
• W2054255517 creator A5002320422 @default.
• W2054255517 creator A5007214576 @default.
• W2054255517 creator A5018208681 @default.
• W2054255517 creator A5021763395 @default.
• W2054255517 creator A5033940481 @default.
• W2054255517 creator A5035058630 @default.
• W2054255517 creator A5035673194 @default.
• W2054255517 creator A5042202079 @default.
• W2054255517 creator A5044666227 @default.
• W2054255517 creator A5049475287 @default.
• W2054255517 creator A5049504158 @default.
• W2054255517 creator A5051084648 @default.
• W2054255517 creator A5055401685 @default.
• W2054255517 creator A5062095629 @default.
• W2054255517 creator A5072610596 @default.
• W2054255517 creator A5076365826 @default.
• W2054255517 creator A5083934929 @default.
• W2054255517 creator A5088676411 @default.
• W2054255517 date "2013-03-08" @default.
• W2054255517 modified "2023-10-18" @default.
• W2054255517 title "The Polo-Like Kinase 1 (PLK1) Inhibitor NMS-P937 Is Effective in a New Model of Disseminated Primary CD56+ Acute Monoblastic Leukaemia" @default.
• W2054255517 cites W1496335924 @default.
• W2054255517 cites W1964880561 @default.
• W2054255517 cites W1967458561 @default.
• W2054255517 cites W1975776530 @default.
• W2054255517 cites W1998130196 @default.
• W2054255517 cites W2003455709 @default.
• W2054255517 cites W2005591228 @default.
• W2054255517 cites W2022260878 @default.
• W2054255517 cites W2024143075 @default.
• W2054255517 cites W2036520923 @default.
• W2054255517 cites W2043085463 @default.
• W2054255517 cites W2050368453 @default.
• W2054255517 cites W2051315018 @default.
• W2054255517 cites W2054744711 @default.
• W2054255517 cites W2058153393 @default.
• W2054255517 cites W2059980106 @default.
• W2054255517 cites W2062483137 @default.
• W2054255517 cites W2064310798 @default.
• W2054255517 cites W2067473835 @default.
• W2054255517 cites W2080791584 @default.
• W2054255517 cites W2082973537 @default.
• W2054255517 cites W2085066928 @default.
• W2054255517 cites W2090982381 @default.
• W2054255517 cites W2105428856 @default.
• W2054255517 cites W2116068077 @default.
• W2054255517 cites W2122659245 @default.
• W2054255517 cites W2125208016 @default.
• W2054255517 cites W2127132180 @default.
• W2054255517 cites W2169403989 @default.
• W2054255517 cites W2170846829 @default.
• W2054255517 cites W4312790597 @default.
• W2054255517 cites W99410290 @default.
• W2054255517 doi "https://doi.org/10.1371/journal.pone.0058424" @default.
• W2054255517 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/3592825" @default.
• W2054255517 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/23520509" @default.
• W2054255517 hasPublicationYear "2013" @default.
• W2054255517 type Work @default.
• W2054255517 sameAs 2054255517 @default.
• W2054255517 citedByCount "31" @default.
• W2054255517 countsByYear W20542555172013 @default.
• W2054255517 countsByYear W20542555172014 @default.
• W2054255517 countsByYear W20542555172015 @default.
• W2054255517 countsByYear W20542555172016 @default.
• W2054255517 countsByYear W20542555172017 @default.
• W2054255517 countsByYear W20542555172018 @default.
• W2054255517 countsByYear W20542555172019 @default.
• W2054255517 countsByYear W20542555172020 @default.
• W2054255517 countsByYear W20542555172021 @default.
• W2054255517 countsByYear W20542555172022 @default.
• W2054255517 countsByYear W20542555172023 @default.
• W2054255517 crossrefType "journal-article" @default.
• W2054255517 hasAuthorship W2054255517A5002145082 @default.
• W2054255517 hasAuthorship W2054255517A5002320422 @default.
• W2054255517 hasAuthorship W2054255517A5007214576 @default.
• W2054255517 hasAuthorship W2054255517A5018208681 @default.
• W2054255517 hasAuthorship W2054255517A5021763395 @default.
• W2054255517 hasAuthorship W2054255517A5033940481 @default.
• W2054255517 hasAuthorship W2054255517A5035058630 @default.
• W2054255517 hasAuthorship W2054255517A5035673194 @default.
• W2054255517 hasAuthorship W2054255517A5042202079 @default.
• W2054255517 hasAuthorship W2054255517A5044666227 @default.
• W2054255517 hasAuthorship W2054255517A5049475287 @default.
• W2054255517 hasAuthorship W2054255517A5049504158 @default.
• W2054255517 hasAuthorship W2054255517A5051084648 @default.
• W2054255517 hasAuthorship W2054255517A5055401685 @default.
• W2054255517 hasAuthorship W2054255517A5062095629 @default.
• W2054255517 hasAuthorship W2054255517A5072610596 @default.
• W2054255517 hasAuthorship W2054255517A5076365826 @default.
• W2054255517 hasAuthorship W2054255517A5083934929 @default.
• W2054255517 hasAuthorship W2054255517A5088676411 @default.
• W2054255517 hasBestOaLocation W20542555171 @default.
• W2054255517 hasConcept C121608353 @default.
• W2054255517 hasConcept C126322002 @default.
• W2054255517 hasConcept C146276462 @default.

• next